# Central Glass Co., Ltd. – FDA Inspection, Sep 15, 2023

Source: https://www.keypedia.com/records/fda_inspections/central-glass-co-ltd/b74e100d-304c-417b-8d7f-e51ec4db76f9
Source feed: FDA_Inspections

> FDA inspection 1218134 of Central Glass Co., Ltd., September 15, 2023. Classification: Voluntary Action Indicated (VAI). Form 483 issued. 4 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1218134
- Company Name: Central Glass Co., Ltd.
- Inspection Date: 2023-09-15
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 0

## Related Documents

- [FDA Inspection 1060825 - 2018-06-29](https://www.keypedia.com/records/fda_inspections/central-glass-co-ltd/6d9dfa94-1ee5-40fc-8f34-c8ee4f8064ff)
- FDA Inspection 897474 - 2014-09-19
- FDA Inspection 777823 - 2012-02-09
- FDA Inspection 614517 - 2009-07-24

## Related Officers

- [Teresa I. Navas](https://www.keypedia.com/people/teresa-i-navas/43f747c0-18c2-4630-bab9-936204aa93aa)

Company: https://www.keypedia.com/companies/central-glass-co-ltd/df9e20f9-4cd5-4ab6-b166-4216c0d628db

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c